Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Testosterone Gel for Poor Ovarian Responders
NCT02418572Phase 3Terminated
- Sponsor
- Fundación Dexeus Mujer
- Start
- Apr 2015
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of Testosterone TEPI patch in poor ovarian response (POR), sponsored by Fundación Dexeus Mujer. Started Apr 2015; status: terminated.
02
Drugs
Testosterone TEPI patch
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT02418572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418572.